https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
Low-dose sIPV administered as a three-dose vaccination was safe and immunogenic compared to cIPV. Low-dose sIPV administered as a three-dose vaccination was safe and immunogenic compared to cIPV.While the development of effective combined chemoradiation regimens for esophageal cancers has resulted in statistically significant survival benefits, the majority of patients treated with curative intent develop locoregional and/or distant relapse. Further improvements in disease control and survival will require the development